Price
Financials
Consolidated, Rs crore| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 358.49 | 374.50 | 306.67 | 270.29 | 273.53 | 281.29 | 285.84 | 298.43 | 301.32 | 345.74 | 373.78 | 446.85 |
| Expenses | 355.12 | 371.07 | 317.32 | 272.69 | 278.25 | 304.99 | 311.04 | 292.37 | 323.93 | 356.10 | 398.97 | 455.23 |
| Operating Profit | 3.37 | 3.43 | -10.65 | -2.40 | -4.72 | -23.70 | -25.20 | 6.06 | -22.61 | -10.36 | -25.19 | -8.38 |
| OPM % | 0.94% | 0.92% | -3.47% | -0.89% | -1.73% | -8.43% | -8.82% | 2.03% | -7.50% | -3.00% | -6.74% | -1.88% |
| Other Income | 9.71 | 20.13 | 18.46 | 28.75 | -167.39 | -14.06 | 21.91 | 25.38 | 5.34 | 13.62 | 12.80 | 12.83 |
| Interest | 0.24 | 0.24 | 0.27 | 0.10 | 0.06 | 0.05 | 0.01 | 0.09 | 0.04 | 0.17 | 0.49 | 0.59 |
| Depreciation | 2.20 | 2.31 | 2.53 | 1.61 | 1.45 | 1.43 | 1.34 | 1.17 | 1.33 | 2.17 | 1.94 | 1.89 |
| Profit before tax | 10.64 | 21.01 | 5.01 | 24.64 | -173.62 | -39.24 | -4.64 | 30.18 | -18.64 | 0.92 | -14.82 | 1.97 |
| Tax % | -23.03% | 3.86% | -583.03% | -102.80% | -13.17% | 1.99% | -478.45% | 11.90% | -17.17% | 59.78% | -12.48% | -0.51% |
| Net Profit | -12.20 | -3.23 | 21.58 | 40.96 | -154.78 | -37.80 | 17.57 | 26.59 | -15.44 | 0.37 | -12.97 | 1.99 |
| EPS in Rs | -2.55 | -0.24 | 5.17 | 9.79 | -34.39 | -8.47 | 4.30 | 7.52 | -3.99 | 0.36 | -3.51 | 0.80 |
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 89 | 135 | 162 | 222 | 388 | 551 | 1,798 | 1,060 | 1,432 | 1,159 | 1,375 | 1,468 |
| Expenses | 116 | 155 | 175 | 255 | 440 | 561 | 684 | 1,168 | 1,456 | 1,177 | 1,371 | 1,534 |
| Operating Profit | -28 | -20 | -13 | -33 | -52 | -10 | 1,114 | -107 | -24 | -19 | 4 | -67 |
| OPM % | -31% | -15% | -8% | -15% | -13% | -1.9% | 62% | -10% | -1.7% | -1.6% | 0.3% | -4.5% |
| Other Income | -0 | 2 | 7 | 0 | 1 | 1 | 3 | -5 | 4 | -179 | 1 | 45 |
| Interest | 2 | 3 | 1 | 3 | 1 | 3 | 3 | 2 | 1 | 0 | 1 | 1 |
| Depreciation | 7 | 7 | 6 | 6 | 5 | 4 | 4 | 8 | 9 | 6 | 7 | 7 |
| Profit before tax | -37 | -28 | -12 | -42 | -58 | -16 | 1,109 | -122 | -30 | -204 | -2 | -31 |
| Tax % | -1% | 2% | 19% | 3% | -9% | 4% | 22% | -19% | -119% | -34% | -39% | |
| Net Profit | -37 | -29 | -15 | -43 | -52 | -17 | 865 | -99 | 6 | -134 | -1 | -26 |
| EPS in Rs | -11.51 | -9.00 | -3.73 | -11.81 | -12.19 | -3.27 | 197.05 | -22.70 | 2.79 | -28.66 | 0.37 | -6.34 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| 10 Years | 5 Years | 3 Years | TTM | 1 Year | Last Year | |
|---|---|---|---|---|---|---|
| Compounded Sales Growth | 32% | 20% | 9% | 29% | ||
| Compounded Profit Growth | 8% | 18% | 27% | -154% | ||
| Stock Price CAGR | 20% | 0% | 2% | -9% | ||
| Return on Equity | -4% | -2% | 2% | 0% |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 32 | 32 | 32 | 32 | 32 | 32 | 32 | 32 | 32 | 32 | 32 | 32 |
| Reserves | 223 | 186 | 163 | 144 | 111 | 178 | 168 | 795 | 722 | 731 | 638 | 609 |
| Borrowings | 5 | 19 | 21 | 12 | 2 | 8 | 12 | 2 | 9 | 4 | 1 | 26 |
| Other Liabilities | 22 | 20 | 35 | 48 | 86 | 98 | 80 | 449 | 441 | 383 | 300 | 264 |
| Total Liabilities | 281 | 256 | 251 | 235 | 230 | 316 | 293 | 1,278 | 1,204 | 1,149 | 970 | 930 |
| Fixed Assets | 137 | 126 | 125 | 117 | 116 | 114 | 110 | 93 | 107 | 110 | 102 | 117 |
| CWIP | 3 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 10 | 1 |
| Investments | 22 | 10 | 17 | 46 | 36 | 56 | 43 | 666 | 513 | 676 | 575 | 519 |
| Other Assets | 119 | 120 | 110 | 71 | 77 | 146 | 139 | 518 | 583 | 363 | 283 | 294 |
| Total Assets | 281 | 256 | 251 | 235 | 230 | 316 | 293 | 1,278 | 1,204 | 1,149 | 970 | 930 |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operating Activity | -12 | -12 | -2 | -49 | -30 | -69 | -31 | -207 | -112 | 36 | -17 | -74 |
| Cash from Investing Activity | 7 | -1 | 4 | 15 | -2 | -22 | 21 | 220 | 133 | -34 | -1 | 171 |
| Cash from Financing Activity | 4 | 13 | 5 | 33 | 26 | 103 | 4 | -11 | -2 | -2 | -0 | -80 |
| Net Cash Flow | -1 | -0 | 7 | -2 | -6 | 11 | -5 | 1 | 19 | -0 | -19 | 18 |
| Free Cash Flow | -28 | -18 | -0 | -55 | -33 | -71 | -31 | -212 | -128 | 22 | -27 | -89 |
| CFO/OP | 106% | 43% | 17% | 377% | 89% | 133% | 288% | -8% | 104% | -172% | 68% | -1,729% |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 87 | 34 | 52 | 9 | 13 | 14 | 9 | 4 | 12 | 9 | 3 | 2 |
| Inventory Days | 337 | 91 | 80 | 73 | 59 | 77 | 57 | 71 | 69 | 34 | 40 | 44 |
| Days Payable | 165 | 38 | 69 | 24 | 26 | 50 | 29 | 21 | 22 | 13 | 21 | 26 |
| Cash Conversion Cycle | 259 | 87 | 62 | 58 | 46 | 41 | 38 | 55 | 59 | 31 | 22 | 20 |
| Working Capital Days | 344 | 182 | 49 | 61 | 61 | 54 | 44 | 46 | 93 | 58 | 47 | 28 |
| ROCE % | -6% | -14% | -12% | -8% | -19% | -25% | -6% | -7% | -11% | -3% | -1% | 0% |
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 73.92% | 73.92% | 73.92% | 73.92% | 73.92% | 73.93% | 74.11% | 74.24% | 74.24% | 74.69% | 74.84% | 74.07% |
| FIIs | 0.32% | 0.49% | 0.56% | 0.61% | 0.99% | 1.71% | 1.60% | 1.88% | 2.04% | 2.25% | 2.17% | 2.29% |
| DIIs | 0.17% | 0.86% | 0.96% | 1.35% | 1.98% | 1.85% | 2.06% | 2.09% | 2.07% | 2.07% | 2.60% | 2.60% |
| Public | 25.60% | 24.73% | 24.57% | 24.12% | 23.11% | 22.50% | 22.21% | 21.79% | 21.65% | 20.99% | 20.38% | 21.02% |
| No. of Shareholders | 14,633 | 14,053 | 14,544 | 14,493 | 15,360 | 14,093 | 13,693 | 13,452 | 13,012 | 12,287 | 11,845 | 11,502 |
Fundamentals
Market Cap₹ 923 Cr.
Current Price₹ 285
Book Value₹ 201
ROCE0.03 %
ROE0.44 %
Dividend Yield0.00 %
Face Value₹ 10.0
Compounded Sales Growth (TTM)29%
Compounded Profit Growth (TTM)-154%
Consolidated figures.
Valuation
Market capRs 868 Cr
Enterprise valueRs 864 Cr
Price to book1.35x
Price to sales0.59x
EV / sales0.59x
Earnings yield-2.32%
P/E, 3-year average400.76x
P/B, 3-year average1.23x
P/E, 5-year average267.78x
P/B, 5-year average1.20x
Profitability
Operating margin (excl. other income)0.29%
Operating margin (incl. other income)0.38%
EBITDA margin-1.50%
Pre-tax margin-2.08%
Net profit margin-1.38%
Net margin, latest quarter0.57%
ROE0.18%
ROCE-0.20%
ROA0.12%
ROE, 3-year average-3.79%
ROCE, 3-year average-10.79%
ROA, 3-year average-2.57%
ROE, 5-year average20.32%
ROCE, 5-year average33.27%
ROA, 5-year average13.26%
ROIC (approx.)-2.82%
Tax rate38.72%
Other income / net worth0.19%
Growth
Sales growth (latest year)18.65%
Sales CAGR, 3 years9.04%
Sales CAGR, 5 years20.08%
Sales growth QoQ19.55%
Sales growth YoY (latest quarter)49.73%
Profit growth YoY (latest quarter)-89.38%
Per share
EPS (TTM)Rs -6.35
EPS (latest year)Rs 0.37
EPS (latest quarter)Rs 0.80
EPS, 3-year averageRs -8.50
EPS, 5-year averageRs 29.77
Book value per shareRs 201.47
Sales per shareRs 461.39
Cash flow per shareRs -23.21
Free cash flow per shareRs -27.98
Efficiency
Asset turnover1.48x
Fixed asset turnover11.79x
Inventory turnover8.43x
Inventory days43 days
Debtor days2 days
Debtors turnover179.47x
Creditor days26 days
Cash conversion cycle20 days
Working capital days28 days
Leverage
Total debtRs 26 Cr
Cash and bankRs 30 Cr
Net debtRs -5 Cr
Debt to equity0.04x
Interest coverage-22.70x
Owners' fund to total sources68.89%
Debt to assets2.76%
Cash flow
Cash from Operating Activity (latest year)Rs -74 Cr
Cash from Investing Activity (latest year)Rs 171 Cr
Cash from Financing Activity (latest year)Rs -80 Cr
Net Cash Flow (latest year)Rs 18 Cr
Free cash flow (latest year)Rs -89 Cr
FCFE (approx.: FCF + change in debt)Rs -64 Cr
Cash from ops / profit, 5 years-0.59x
Statement figures
Net sales (TTM)Rs 1,468 Cr
Net sales (latest year)Rs 1,375 Cr
Sales (latest quarter)Rs 447 Cr
Operating profit excl. other income (latest year)Rs 4 Cr
Operating profit (latest quarter)Rs -8 Cr
Other income (TTM)Rs 45 Cr
EBITDA (TTM)Rs -22 Cr
PBDT (TTM)Rs -23 Cr
Profit before tax (TTM)Rs -31 Cr
Tax (latest year)Rs -1 Cr
Net profit (TTM)Rs -20 Cr
Net profit (latest year)Rs 1 Cr
Net profit (latest quarter)Rs 3 Cr
Depreciation (TTM)Rs 7 Cr
Depreciation (latest quarter)Rs 2 Cr
Interest (TTM)Rs 1 Cr
Cost of goods sold (latest year)Rs 1,219 Cr
Total expenditure (latest year)Rs 1,371 Cr
Total income (latest year)Rs 1,376 Cr
Share capitalRs 32 Cr
ReservesRs 609 Cr
Shareholders' fundsRs 641 Cr
Total assetsRs 930 Cr
Net blockRs 117 Cr
Capital work in progressRs 1 Cr
InvestmentsRs 519 Cr
ReceivablesRs 8 Cr
InventoryRs 145 Cr
Other liabilitiesRs 264 Cr
Shares outstanding (crore)3.18
Ownership
Promoter holding74.07% (-0.17 in a year)
Computed by MarketFriction from the consolidated statements. Returns use average balances.
P/B 1.36 is at the 36th percentile (median 1.48).
Monthly. Market cap from split-adjusted price; profit and book value as reported by that month. A low percentile means cheap versus its own history, not cheap versus peers.
| Period | HEALTHX | Nifty 50 | Difference |
|---|---|---|---|
| 1 week | -6.1% | -2.8% | -3.3 pts |
| 1 month | -8.4% | -6.8% | -1.6 pts |
| 3 months | -12.6% | -7.6% | -5.0 pts |
| 6 months | +6.2% | +0.4% | +5.8 pts |
| 1 year | -12.0% | -9.9% | -2.1 pts |
| 2 years | -11.0% | -13.6% | +2.5 pts |
| 3 years | +0.3% | +14.2% | -13.8 pts |
| 5 years | -6.4% | +27.9% | -34.3 pts |
1 mutual fund schemes hold about ₹0 Cr.
Over three months 1 bought more and 0 sold (share counts, price move removed).
| Fund | Weight | Est. Cr | 3m shares |
|---|---|---|---|
| Bandhan BSE Healthcare Index Fund | 0.01% | 0 | +7% |
Red flags
F-score 5 of 8No red flags in the latest statements and filings.
Checks on the latest reported years: cash vs profit, accruals, receivables and inventory vs sales, dilution, debt, interest cover, equity, other income, losses, and auditor, top-management, insolvency and regulator filings in the last 12 months. A flag asks for an explanation; it is not a verdict.
Latest quarter
Jun 2026Sales ₹447 Cr +49.7% vs Jun 2025.
Net profit ₹2 Cr -92.5%.
Activity
Compare| Company | Mcap (Cr) | P/E | ROCE |
|---|---|---|---|
| Dr Lal Pathlabs Ltd | 32,737 | 58.2 | 28.0 % |
| Vijaya Diagnostic Centre Ltd | 15,192 | 81.0 | 20.5 % |
| Metropolis Healthcare Ltd | 11,665 | 56.0 | 17.8 % |
| Thyrocare Technologies Ltd | 8,708 | 48.2 | 35.4 % |
| Nephrocare Health Services Ltd | 6,671 | 78.4 | 15.3 % |
| Suraksha Diagnostic Ltd | 1,847 | 51.6 | 17.3 % |
| Krsnaa Diagnostics Ltd | 1,791 | 18.1 | 12.7 % |
| 3B Blackbio DX Ltd | 1,396 | 25.1 | 25.5 % |
| One Global Service Provider Ltd | 1,046 | 14.1 | 87.0 % |
| Gaudium IVF and Women Health Ltd | 830 | 35.9 | 29.3 % |
| Chandan Healthcare Ltd | 581 | 22.1 | 23.3 % |
| Pramodini Medicare Ltd | 259 | 14.9 | 41.8 % |
| Aspira Pathlab & Diagnostics Ltd | 148 | 2.84 % | |
| Choksi Laboratories Ltd | 132 | 69.2 | 9.44 % |
| Star Imaging and Path Lab Ltd | 131 | 6.80 | 26.1 % |
No bulk or block deals on record.
| Ex-date | Action | Factor |
|---|---|---|
| 2024-09-23 | Annual General Meeting | |
| 2023-09-22 | Annual General Meeting | |
| 2022-09-21 | Annual General Meeting | |
| 2021-09-20 | Annual General Meeting | |
| 2020-09-03 | Annual General Meeting | |
| 2019-09-20 | Annual General Meeting | |
| 2018-08-03 | Annual General Meeting | |
| 2017-07-28 | Annual General Meeting | |
| 2016-09-16 | Annual General Meeting | |
| 2015-09-16 | Annual General Meeting | |
| 2014-08-04 | Annual General Meeting | |
| 2013-08-02 | Annual General Meeting | |
| 2012-07-23 | Annual General Meeting / Dividend Rs 1.00 Per Share | |
| 2011-07-25 | Annual General Meeting And Dividend Re.1/- Per Share |
No announcements in our files yet.
Company filings to NSE, newest first. Routine notices (trading window, newspaper copies) are left out. Click a row for the filing.
No short selling reported to NSE in our files.
Short sales disclosed by brokers to NSE, by trade date. Collected since late September 2026.
EPS in the scrip is zero (4 trailing quarters)Less than 100 unique PAN traded in previous 30 daysLoss making
Quick answers
What is the market cap of Health X Platform Ltd?
Health X Platform Ltd (HEALTHX) has a market capitalisation of Rs 923 Cr. at the 2026-10-01 close.
What were Health X Platform Ltd's latest quarterly results?
In the Jun 2026 quarter, Health X Platform Ltd sales was Rs 447 Cr (+49.7% vs Jun 2025) and net profit was Rs 2 Cr.
What is the 52-week high and low of Health X Platform Ltd?
The 52-week high is Rs 363.00 and the 52-week low is Rs 252.50.